USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3.

The FEBS journal (2020-01-07)
Qiaoqiao Zhou, Cheng Cheng, Yujuan Wei, Jing Yang, Wanzhu Zhou, Qiuyi Song, Mengxiang Ke, Wanyao Yan, Ling Zheng, Yu Zhang, Kun Huang
RESUMEN

Tumor necrosis factor α (TNFα)- and interleukin 1β (IL-1β)-induced nuclear factor-κB (NF-κB) activation play key roles in inflammation, immunity, and cancer development. Here, we identified one of the deubiquitinating enzymes (DUBs), ubiquitin-specific protease 15 (USP15), as a positive regulator in both TNFα- and IL-1β-induced NF-κB activation. Overexpression of USP15 potentiated TNFα- or IL-1β-triggered NF-κB activation and downstream gene transcription, whereas knockdown of USP15 had opposite effects. Mechanistically, upon TNFα stimulation, USP15 showed an enhanced interaction with transforming growth factor-β activated kinase-1 (TAK1)-TAK1 binding protein (TAB) complex to inhibit the proteolysis of TAB2/3 by different pathways. Apart from deubiquitination dependently inducing cleavage of lysine 48-linked TAB2 ubiquitination, USP15 also DUB independently inhibited lysosome-associated TAB2 degradation, thus enhanced TAB2 stabilization. For TAB3, USP15 inhibited NBR1-mediated selective autophagic TAB3 degradation independent of its deubiquitinating activity. Together, our results reveal a novel USP15-mediated mechanism through which efficient NF-κB activation is achieved by differentially maintaining the TAB2/3 stability.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
3-Methyladenine, autophagy inhibitor
Sigma-Aldrich
Monoclonal Anti-HA antibody produced in mouse, clone HA-7, purified from hybridoma cell culture
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)
Sigma-Aldrich
Monoclonal Anti-Actin antibody produced in mouse, clone AC-40, ascites fluid